Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 1
2006 2
2007 2
2008 4
2009 4
2010 2
2011 4
2012 4
2013 3
2014 7
2015 4
2016 9
2017 4
2018 4
2019 6
2020 12
2021 6
2022 7
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Control and resolution mechanisms of the inflammatory response.
Baizabal-Aguirre VM, Rosales C, López-Macías C, Gómez MI. Baizabal-Aguirre VM, et al. Among authors: lopez macias c. Mediators Inflamm. 2014;2014:387567. doi: 10.1155/2014/387567. Epub 2014 Dec 1. Mediators Inflamm. 2014. PMID: 25525299 Free PMC article. No abstract available.
[Antibodies and protection against COVID-19].
López-Macías C, Rivera-Hernández T. López-Macías C, et al. Rev Med Inst Mex Seguro Soc. 2020 Apr 13;58(2):76-77. doi: 10.24875/RMIMSS.M20000001. Rev Med Inst Mex Seguro Soc. 2020. PMID: 34101548 Spanish.
Control and Resolution Mechanisms of the Inflammatory Response 2016.
Baizabal-Aguirre VM, Rosales C, López-Macías C, Gómez MI. Baizabal-Aguirre VM, et al. Among authors: lopez macias c. Mediators Inflamm. 2016;2016:3591797. doi: 10.1155/2016/3591797. Epub 2016 Dec 29. Mediators Inflamm. 2016. PMID: 28119541 Free PMC article. No abstract available.
Chronic Comorbidities in Middle Aged Patients Contribute to Ineffective Emergency Hematopoiesis in Covid-19 Fatal Outcomes.
Romo-Rodríguez R, Gutiérrez-de Anda K, López-Blanco JA, Zamora-Herrera G, Cortés-Hernández P, Santos-López G, Márquez-Domínguez L, Vilchis-Ordoñez A, Ramírez-Ramírez D, Balandrán JC, Parra-Ortega I, Resendis-Antonio O, Domínguez-Ramírez L, López-Macías C, Bonifaz LC, Arriaga-Pizano LA, Cérbulo-Vázquez A, Ferat-Osorio E, Chavez-González A, Treviño S, Brambila E, Ramos-Sánchez MÁ, Toledo-Tapia R, Domínguez F, Bayrán-Flores J, Cruz-Oseguera A, Reyes-Leyva JR, Méndez-Martínez S, Ayón-Aguilar J, Treviño-García A, Monjaraz E, Pelayo R. Romo-Rodríguez R, et al. Among authors: lopez macias c. Arch Med Res. 2023 Apr;54(3):197-210. doi: 10.1016/j.arcmed.2023.03.003. Epub 2023 Mar 15. Arch Med Res. 2023. PMID: 36990888 Free PMC article.
Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico.
Ponce-de-León S, Torres M, Soto-Ramírez LE, Calva JJ, Santillán-Doherty P, Carranza-Salazar DE, Carreño JM, Carranza C, Juárez E, Carreto-Binaghi LE, Ramírez-Martínez L, Paz De la Rosa G, Vigueras-Moreno R, Ortiz-Stern A, López-Vidal Y, Macías AE, Torres-Flores J, Rojas-Martínez O, Suárez-Martínez A, Peralta-Sánchez G, Kawabata H, González-Domínguez I, Martínez-Guevara JL, Sun W, Sarfati-Mizrahi D, Soto-Priante E, Chagoya-Cortés HE, López-Macías C, Castro-Peralta F, Palese P, García-Sastre A, Krammer F, Lozano-Dubernard B. Ponce-de-León S, et al. Among authors: lopez macias c. NPJ Vaccines. 2023 May 10;8(1):67. doi: 10.1038/s41541-023-00662-6. NPJ Vaccines. 2023. PMID: 37164959 Free PMC article.
Potential of ATR-FTIR-Chemometrics in Covid-19: Disease Recognition.
Calvo-Gomez O, Calvo H, Cedillo-Barrón L, Vivanco-Cid H, Alvarado-Orozco JM, Fernandez-Benavides DA, Arriaga-Pizano L, Ferat-Osorio E, Anda-Garay JC, López-Macias C, López MG. Calvo-Gomez O, et al. Among authors: lopez macias c. ACS Omega. 2022 Aug 25;7(35):30756-30767. doi: 10.1021/acsomega.2c01374. eCollection 2022 Sep 6. ACS Omega. 2022. PMID: 36092630 Free PMC article.
[Challenges in the development of vaccines against COVID-19].
Ontiveros-Padilla LA, Rivera-Hernández T, López-Macías C. Ontiveros-Padilla LA, et al. Among authors: lopez macias c. Rev Med Inst Mex Seguro Soc. 2020 Sep 21;58(Supl 2):S116-118. doi: 10.24875/RMIMSS.M20000122. Rev Med Inst Mex Seguro Soc. 2020. PMID: 34695323 Spanish.
The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.
Wong-Baeza I, Alcántara-Hernández M, Mancilla-Herrera I, Ramírez-Saldívar I, Arriaga-Pizano L, Ferat-Osorio E, López-Macías C, Isibasi A. Wong-Baeza I, et al. Among authors: lopez macias c. J Biomed Biotechnol. 2010;2010:254521. doi: 10.1155/2010/254521. Epub 2010 Jan 21. J Biomed Biotechnol. 2010. PMID: 20145703 Free PMC article. Review.
B1b cells recognize protective antigens after natural infection and vaccination.
Cunningham AF, Flores-Langarica A, Bobat S, Dominguez Medina CC, Cook CN, Ross EA, Lopez-Macias C, Henderson IR. Cunningham AF, et al. Among authors: lopez macias c. Front Immunol. 2014 Oct 31;5:535. doi: 10.3389/fimmu.2014.00535. eCollection 2014. Front Immunol. 2014. PMID: 25400633 Free PMC article. Review.
91 results